Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 131-138, February 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nigam, V. N.
Right arrow Articles by Cantero, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nigam, V. N.
Right arrow Articles by Cantero, A.

Limiting Factors for Glycogen Storage in Tumors

I. Limiting Enzymes*

Vijai N. Nigam, Helen L. MacDonald{dagger} and A. Cantero

( Montreal Cancer Institute, Research Laboratories, Notre Dame Hospital and Université de Montreal, Montreal, Canada)

The paper presents a study of various enzymes involved in the final accumulation of glycogen in tumor tissues. The solid tumors used are: Novikoff hepatoma, Walker 256 carcinosarcoma, Sarcoma 37, leukemia, and melanoma. It was observed that tumor tissues showed lower activity of phosphoglucomutase and glycogen synthetase as compared with that of normal liver and muscle. All tumors studied except melanoma also showed decreased UDPG1 pyrophosphorylase levels. Activities for ATP- and UTP-regenerating enzymes—namely, pyruvate kinase and nucleoside disphosphokinase—in tumors were close to those found in normal tissues, thus providing sufficient quantities of cofactors (ATP and UTP) and energy for the polymerization process. UDPG was not diverted to UDPGA in tumors because of the absence of UDPG dehydrogenase. The lesion could be best described as a defective system for glycogen synthesis, owing to low activities of the enzymes involved in the synthetic process (phosphoglucomutase and glycogen synthetase) which were unable to accomplish efficient transformation of G-6-P to G-1-P and of UDPG to glycogen, in the presence of competing high rates of tumor glycolysis and normal polysaccharide degradation by phosphorylase.

* This work was supported by grants from the National Cancer Institute of Canada.

Presented at the meeting of American Society of Biological Chemists in Atlantic City, April 10, 1961.

1 The abbreviations used are: AMP, adenosine monophosphate; ADP, adenosine diphosphate; ATP, adenosine triphosphate; UDP, uridine diphosphate; UTP, uridine triphosphate; UDPG, uridine diphosphate glucose; UDPGA, uridine diphosphate glucuronic acid; G-1-P, glucose-1-phosphate; G-6-P, glucose-6-phosphate; DPN, diphosphopyridine nucleotide; TPN, triphosphopyridine nucleotide; GDP, guanosine diphosphate; CDP, cytidine diphosphate; IDP, inosine diphosphate.

{dagger} Technical assistant.

Received 5/22/61.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.